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ABSTRACT 
HETEROGENEITY OF FUNCTION IN HUMAN CD4~8- 
T-CELL CLONES FROM THE PERIPHERY 
Lisa Ann Straus 
1988 
The T-cell receptor (TCR) is the fundamental protagonist in the 
human immune system, in that it recognizes foreign antigen and initiates 
the immune response. An antigen is recognized in the context of self 
major histocompatibility (MHC) encoded molecules on the surface of 
antigen presenting cells. The capacity for dual recognition of both self 
and antigen, essential to healthy immune function, is thought to be 
aquired in the thymus by developing T-cells. 
Recently, another rearranging gene, similar to immunoglobulin genes, 
and specific for T-cells has been discovered and is termed Ty. Ty 
mRNA appears early in thymocyte development and is postulated to have 
a role in the selection of T-cells specific for recognition of self MHC 
encoded molecules. The central questions about the newly discovered 
receptor pertain to its function in the immune system and its relation to 
the Tia3 TCR. 
We used negative selection with monoantibodies to isolate CD4_8“ 
cells from healthy adult peripheral blood and performed functional assays 
on clones from one individual. Phenotypically the clones are immature: 
they do not express the Tia|3 TCR, nor do they express the CD4 or CD8 
markers which distinquish T helper and T suppressor cells respectively. 
The clones demonstrate a heterogeneous cytotoxic response to different 
targets including K562, T-cell tumor lines, and B-cell lines. In helper 
cell assays two of the clones show the capacity to induce B-cell activa¬ 
tion. This indicates that the Ty receptor is functional in the periphery 
and represents a cell line distinct from both Tia|3 bearing cells and cells 
of NK lineage. The cytotoxic and inducer capacity of these Ty clones is 
not MHC restricted, but does demonstrate clonotypic specificity not seen 
before in Ty expressing cells. 
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The T-cell differentiation antigens detected by monoclonal antibodies 
are named according to the cluster of differentiation (CD) approach to 
leukocyte typing.* 
Name Used Human Mouse 
CD1 T6, Leu 6 TL 
CD2 Til, Leu 5 
CD3 T3, Leu 4 
CD4 T4, Leu 3 L3T4 
CD5 Tl, Leu 1 Ly-1 




TCR, Tia3 CD6 
*Berhard, A. et al. eds., "Human Leukocyte Differentiation Antigens 
Detected by Monoclonal Antibodies," Leukocyte Typing (Berlin: Springer- 
Verlag, 1984), 9-121. Table adapted from "Note on Nomenclature," 
Nature 326 (1987):660. 

INTRODUCTION 
The human immune system is a complex regulation of responses to a 
potentially infinite array of foreign invaders and changes in the host 
organism. There must be the capacity to recognize foreign antigen 
either soluble or cellularly incorporated, initiate an effective response, 
and then regulate that action such that only the target is eliminated. 
For efficient protection it is necessary that over a lifetime an organism 
develops a memory for and quick response to some antigens and a 
tolerance for self. 
The cells involved in specific recognition of foreign antigen are 
bone marrow derived (B) and thymus derived (T) lymphocytes. The B 
and T cells respond to circulating and cellularly bound antigen, respec¬ 
tively. The T cells are the regulatory arm of the system: able to induce 
or supress B cell activation, as well as carrying out effector responses 
to intracellular and cellular signals. 
T lymphocytes are activated by recognition of antigen in the context 
of major histocompatibility complex (MHC) coded cell surface glycopro¬ 
teins, or by recognition of foreign MHC molecules, on any cell surface.1 
In the first instance there is a dual recognition of self and of antigen 
and recognition of one or the other is insufficient for activation.2 This 
phenomena of recognition is termed 'MHC restriction' because a response 
to the antigen can only be initiated if the antigen is presented on a cell 
which also has the MHC antigen of the host organism,3’4 
There are several possible purposes for this restriction a) to prevent 
autoaggression when no antigen is present, b) to ensure a swift response 
to foreign cellular antigens and c) to focus T cell action on the cell 

surface rather than upon soluble antigen.5 The MHC markers which are 
identified by T-cells are unique to an individual. Class I histocompati¬ 
bility molecules are expressed on all cell surface membranes and class II 
histocompatibility molecules are primarily expressed on lymphoid cells. 
The different MHC molecules are recognized by subsets of T-cells, 
distiquished by cell surface molecules, CD4 and CD8.6>7 The CD4+ 
T-cells recognize class II MHC encoded molecules on other lymphocytes 
and function as helper cells. The CD8+ lymphocytes recognize class I 
MHC encoded proteins on other cells and function as cytotoxic or sup¬ 
pressor T-cells. 
The simultaneous recognition of antigen and MHC molecule is 
performed by the T-cell receptor (TCR).8 The question of whether this 
molecular complex is two different receptors or a single receptor with 
dual specificity has been debated9 with opinion tending towards the 
latter description. Discussion of Pernis’ proposal of one and a half 
receptors10 shall be considered later. 
Inherent in each T-cell receptor structure is the capacity to 
recognize a specific antigen when properly presented. Considering the 
unlimited possible antigens to be encountered, the system must be able 
to generate an extremely diverse range of antigen specific receptors. 
The diversity required is generated by several mechanisms including DNA 
rearrangements and somatic mutations.11 The expression of unique com¬ 
binations of variable (V), joining (J), and constant (C) gene regions 
serves to generate the panoply of receptors needed.12 The capacity to 
transpose gene segments in order to generate unique peptide sequences 
in a conserved structure is characteristic of the immunoglobulin super- 
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gene family.13 The genes for the V, J, and C regions of the TOR are 
similar in size and sequence to those which encode the immunoglobulin 
proteins.14,13'16,17 
The TCR is a disulfide linked 90 K heterodimer (Ti), composed of a, 
a 48-54 K acidic molecule, and (3, an electrophoretically more basic 40-44 
K subunit.18 These transmembrane glycoproteins each have variable and 
constant regions encoded by genes of the immunoglobulin supergene 
family.19,20 The TCR is noncovalently associated with the CD3 
molecule.21 The CD3 molecule is composed of three noncovalently 
linked, nonpolymorphic peptides (CD3y 25K, CD35 20K, and CD3e 
20K).22,23 (Figure 1) Evidence to support the linkage of Ti(3 and CD3 
includes the stoichiometric relation of CD3 and Tia(3 and the ability to 
coimmunoprecipitate the two molecules.24,23 The CD3 molecule is 
thought to function in transmembrane signaling events related to TCR 
activation.26 Perturbation of the CD3 molecule can induce or inhibit 
TCR activation,27 and leads to an increase in cytoplasmic free Ca+ + .28 
Binding of anti-CD3 mAb can cause comodulation (via endocytosis29) of 
the TCR, or serve as an agonist producing T-cell activation.30 Incuba¬ 
tion with a low concentration of mAb to CD3 induces proliferation, 
lymphokine production, and cytolysis while higher concentrations of anti- 
CD3 inhibit these functions.31,32 
In order to learn more about T-cell function and the TCR inves¬ 
tigators have explored thymocyte development.33,34 Prothymocytes 
migrate from the bone marrow to the thymic cortex. The 'early' stage 
of T-cell ontogeny is identified as that 10% of thymocytes which express 
T9, T10 and CD2. The 'common' stage cells, representing 70% of thymo- 
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cytes, also in the thymic cortex, express CD4, CD8, CD1, T5, T10 and 
CD2 markers concurrently. In the process of maturing the thymocytes 
lose the CD1 antigen and differentiate into either CD4 + 8" or CD4_8 + 
subgroups. In the final stage of development, which takes place in the 
medulla of the thymus and includes 10% of all thymocytes, the cells 
aquire the Ti/CD3 complex and are prepared to circulate in the peri¬ 
phery.35 The mature thymocyte has a TCR/CD3 complex T12, CD2, CDS 
and either a CD4 or CD8 marker. The T10 marker is lost when the 
T-cells migrate to the periphery but does appear on 10% of non T-cells 
in normal adult blood. (Figure 2) Umiel's research in T-cell ontogeny 
revealed a population of immunocompetent CD3/TCR* cells in the thymic 
cortex.36 
In order to trace TCR development specifically, investigators have 
delineated the order of appearance of the gene transcripts for Tia and 
Tip in humans37’38'39 and in mice40,41’42. Gene transcripts for the Tip 
are present at the earliest stage of human thymic development in the 
form of an incomplete 1.0 Kb transcript for the Tip D-J-C region. The 
Tip transcripts are found in greatest number during the intermediate or 
common stage of development in the cortex. This is in contrast to the 
Tia which is undetectable in the earliest stage of development and only 
reaches peak production when the cells are in their final stage of matu¬ 
ration. This discrete order of expression parallels the transcription of 
immunoglobulin genes.43 
In pursuit of the 1° structure of the Tia, Saito, et al. examined the 
cDNA from murine alloreactive CTLs and found a rearranged and ex¬ 
pressed gene which they postulated was a second T-cell receptor.44,45 
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They discovered that the gene included variable (V) and constant (C) 
domains with distinct homology to the immunoglobulin genes and cysteine 
residues in position for the formation of S-S bonds in the peptide. This 
third rearranging gene (after Tip and Tia), unique to T-cells, is called 
Ty. Krantz46 and Hayday47 continued to elucidate the capacity of the 
gene to generate diverse receptor regions and they noted that the mRNA 
is found primarily in cytotoxic rather than helper T-cells. Later studies 
found that five V regions nonrandomly crosshybridize with CySi-4 and 
these recombinations are variably found in immature and mature T- 
cells.48’4930 
Raulet noted that large amounts of Ty mRNA are expressed in fetal 
thymocytes as compared to very little in adult cells.51 During thymo¬ 
cyte maturation first Ty is expressed, then Tip, and finally Tia.32,53 
Noting that most thymocytes die in the thymus and that Ty mRNA is 
present at a specific time in ontogeny Raulet postulates that this new 
receptor is instrumental in the selection of thymocytes that will be MHC 
restricted. In other words, the population with this receptor is active in 
the thymic education of T cells proposed by Zinkernagel54 and Bevan33. 
Another suggestion is that the new receptor recognizes the MHC antigen 
in conjunction with the recognition of antigen by the traditional TCR, 
i.e. dual recognition with two receptors functioning. The latter idea is 
less likely because the Ty molecule itself has not been isolated and the 
genetic evidence for it is not common in normal adult cells. 
The Ty gene has been investigated in humans56'57 and has been 
shown to have six V, two J, and two C regions. The constant gene re¬ 
gions are localized to the short arm of chromosome 7 and display much 
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homology to the corresponding murine genes. One of the Cy region 
rearrangements is deleted in the Ty expressing cells examined which 
could be due to a translational frame shift,58 or a regulatory mechanism 
which determines cell lineage as proposed for leukemic cell lines.59 
LeFranc60 noted that the Jy2C/2 generates a protein without cysteine 
residues for disulfide linking. 
In the continuing search for the Ty molecule Bank61 isolated and 
cloned thymocytes which were CD4~8~ (Double Negative-DN) and CD3 + . 
Northern blots for this cell line showed tY mRNA as well as 1.3 Kb 
message for mature Tip, 1.0 Kb D-J segment of Tip, and an immature 
1.4Kb Tia transcript. Immunoprecipitation with anti-CD3 antibody re¬ 
vealed a novel nondisulfide linked heterodimer of 44Kb and 62Kb pro¬ 
teins (instead of the 40 and 49Kb of the TiaP). When anti-CD3 mAb was 
used as an agonist to activate the clone with the potential new receptor, 
it killed K562, a classic target of cytotoxic lymphoytes. A phenotypi- 
cally and genetically immature cell line was shown to have a molecule 
other than the known TCR associated with CD3 and the capacity to 
function as a mature T cell. 
The fact that the putative new receptor Ty is found on functional 
T-cells is extremely important. This is a step in the definition of the Ty 
receptor, and begins to address the question of how this receptor relates 
to the more common TCR. Further study is required to answer ques¬ 
tions about the purpose of the Ty receptor and the function of T-cell 
receptors in general. Formerly identified genetically, by looking for 
mRNA production, cells expressing the Ty may now be isolated according 
to function. This brings us one step closer to actually analysing the 
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molecule which has so far proved elusive. It will be necessary to con¬ 
sider lymphocyte function and cytotoxicity in particular, in order to 
pursue knowledge of the Tv receptor and the cell lines expressing it. 
Cytotoxicity,62 was recognized in vivo as allograft rejection and then 
in vitro in mixed lymphocyte cytotoxicity (MLC). The cytotoxic T 
lymphocyte (CTL) requires sensitization of the effector cell to the target 
cell over a period of 7-14 days, is MHC restricted, and usually expresses 
the T8 marker. Investigators noticed that some cytotoxic T lymphocytes 
were able to lyse targets without prior exposure. These are natural 
killer (NK) cells which Herberman identifies as large granular lym¬ 
phocytes which kill tumor cells, transformed or infected cells without 
prior immunization.63 Natural killer activity is not MHC restricted. 
The standard for NK activity is the ability to kill K562, an eryth- 
romyeloid ceil line without MHC class I or class II molecules on its 
surface. A subset of NK cells have Fc receptors and lyse targets which 
have been coated with antibody. Molecules on the NK cell surface bind 
to the tails of antibodies bound to a target cell bringing the two cells 
into close proximity and facilitating the subsequent killing of the target 
cell. This ability is termed antibody dependent cellular 
cy to toxicity-ADCC. Hercend, et al. were able to expand our knowledge 
of human NK cells by showing that clonal lines were both phenotypically 
and functionally heterogeneous.64 Some cells which have NK activity 
are CD3* and some are CD3- while all are CD2+ and most are CD8\ 
Cell lines with similar phenotypes have different ranges of cytotoxicity. 
It has been noted that the cytotoxic function of a CD3+ line can be in¬ 
hibited by incubation with anti-CD3 antibody.3® Lanier6= focussed on 
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the CD3 + cells with NK function and observed that this subset is 2-5% 
of all lymphocytes, has an increased level of CD3 expression relative to 
other T-cells, and is Fc receptor positive, i.e. capable of ADCC. Initial¬ 
ly, these cells had low anti-CD8 reactivity, but after three weeks the 
population was 80% CD4_8~. The selected population was only cytotoxic 
in the presence of anti-CD3 or IgG2a coated targets, and in these cases 
it was not antigen specific and did not require MHC recognition. 
Lanier identified a population of CD3 + , Fc+, non MHC restricted CTL 
which are CD4_8“. 
To further explore these possible precursors of CTL, De La Hera 
used negative selection with mAb and complement to isolate a CD3+4_8~ 
population of human thymocytes from children and showed that the 
cytotoxicity to K562 can be inhibited using mAb to CD3.66 Lanier iso¬ 
lated a population of these double negative (DN) cells from normal peri¬ 
pheral blood and noted that their cytotoxic response to K562 was sig¬ 
nificantly augmented by the presence of anti-CD3.67 The seemingly 
opposed effects of the anti-CD3 may be due to different concentrations 
of the mAb used. Lanier and Bank have each isolated a cell population 
with a unique combination of phenotype and function. Do cells with the 
DN phenotype represent a stage in differentiation or a distinct cell line? 
What receptor is operating to allow these cells to function? What can 
we learn about the mechanism and purpose of this type of cytotoxicity? 
Could this function have a role in thymocyte development? At this 
point we know that T-cells which express the potential new receptor are 
phenotypically immature and have cytolytic function. 
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Investigators are expioring several new population sources for cell 
lines which are phenotypically and functionally similar to those thought 
to express the Tv molecule. Brenner68 isolated a DN population from 
the blood of an immunodeficiency patient, which did not have transcripts 
for the Tia or Ti|3 components of the TCR, but did have Ty mRNA. Im- 
munoprecipitation with anti-CD3 revealed a nondisulfide linked hetero¬ 
dimer composed of 55K and 40K peptides. Antibody to synthetic Ty 
proteins also precipitated the 55K molecule. He postulated that this 
heterodimer was Ty5 or Tyy where one Ty was differently glycosylated. 
Weiss characterized the phenotype and genetic complement of Peer, 
a leukemic T-cell line.69 The cells are CD1_2“3 + 4_8~WT31“ and have low 
levels of Tip but no Tia transcripts. (WT31 is a monoantibody to a 
component of the TCR.70) Immunoprecipitation identifies a nondisulfide 
linked 55K molecule, which is either a hetero or homodimer, associated 
with the CD3 molecule. Nowill71 and Moingeon72 et al. have isolated 
clones from fetal (25 wk old) blood which are CD3+4“8 + WT31~ and cyto¬ 
toxic to K562, Molt4, and JM. These cells have mRNA for 1.0 and 1.3Kb 
Tip but not Tia on Northern blots. Immunoprecipitation with anti-CD3 
mAb or with a clonotypic mAb demonstrated a 41/44K disulfide linked 
hetero or homodimer. The clonotypic mAbs inhibited the cytotoxicity of 
the clone. 
If functional Ty expressing cells are an immature form of T-cell 
then one can expect to find them in the thymus, and immunodeficient, 
leukemic, and fetal blood. However, if we are characterizing a distinct 
cell line then evidence of this population may be found in normal adult 
peripheral blood. Perhaps the phenotypically immature cytotoxic T-cells 
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isolated by Lanier correspond to Ty expressing cells. Further charac- 
erization of the chemical and genetic nature of the Ty protein as well 
as its functional capacity is required to answer these questions. 
Borst73 and Brenner74, in separate studies, examined DN clones from 
normal human peripheral blood. Some of these were found to be 
CD3+2+WT31~ and to have Ty mRNA but no Ti(3 or Tia by Northern blot 
and immunoprecipitation studies. The Ty receptor expressed exists 
predominantly as a disulfide linked heterodimer of variously weighted y 
and 5 chains or perhaps a homodimer with the subunits differently 
glycosylated. This is in contrast to the nondisulfide linked Ty receptor 
seen on Peer and IDP2 cell lines. It is hypothesized that the difference 
in linkage of Ty residues on human peripheral blood lymphocytes (PBL) 
depends upon which constant region, Cyi or Cy2, is utilised73. The 
Cy2 gene segment does not have cysteine residues and therefore leads to 
production of a nondisulfide linked homo or heterodimer.60 Murine Ty 
and human Tia3 are invariably disulfide linked. Further study of the 
TCR receptor genes is needed to answer questions concerning the chemi¬ 
cal and genetic nature of the Ty expressing cells and their relation to 
the Tia(3 expressing cells. 
T-cells in the periphery, which do not have functional Tia(3 and do 
express Ty, have been shown to have non-MHC restricted cytotoxic 
capacity. The Ty receptor, similar to the mature Tia(3 receptor, is 
associated with the CD3 molecule and perturbation of that molecule 
alters cytotoxic function. Moigeon, et al.72 were able to further demon¬ 
strate that the Ty receptor itself is functional using a clonotypic mAb 
which inhibited cytotoxicity of a clone from fetal blood. 

Our goal is to understand human T-cells and their function. Spec¬ 
ifically, how is their action mediated by the TCR? The newly discovered 
receptor brings many questions to light. What role does the Ty receptor 
play in the T-cell immune repetoire? What is the range of function of 
this receptor? Though these DN populations lack the traditional T-cell 
antigens associated with helper and suppressor activity perhaps they are 
capable of performing other T-cell functions beyond cytolysis. The Ty 
receptor as it is currently known differs from the Tia(3 in that its 
functions are not MHC restricted. Is there any antigen specific or MHC 
restricted cytotoxicity as yet undetected? 
In order to explore the nature of the Ty receptor as posed in the 
questions above, we have generated DN clones from normal human 
peripheral blood. These cells have the CD3 protein but lack the Tia3 
molecule on the cell surface. Previous studies73-74 have indicated that 
cells of this phenotype express the Ty molecule. Cells from normal 
human adult peripheral blood have been postulated to represent a mature 
stage of the Ty cell and are, therefore, the best candidates for a study 
of the range of function of this receptor. Comparison of a number of 
different clones from one individual offers the opportunity to examine 
the question of receptor specificity. The CD3M_8-WT31_ clones in this 
study are shown to have heterogeneous specificity with regard to 
non-MHC restricted cytotoxicity and helper function. 
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MATERIALS AND METHODS 
Isolation of CD4~8~ T-cells 
Blood was obtained from healthy adults and viable T lymphocytes 
were separated using Ficoll-Hypaque density gradient centrifugation and 
sheep red blood cell (SRBC) (Colorado Serum) rosettes76. The T-cells at 
20 x 106 cells/ml were incubated in OKT4 (1/1000) and OKT8 (1/2000 
final dilution) for 45 minutes at 4°C and then rosetted to ox RBC (Colo¬ 
rado Serum) coupled to rabbit anti-mouse IgG at a final hematocrit of 
2.5%. The CD4~8_ cells which were not rosetted to the ox RBC were 
separated out using Ficoll-Hypaque density gradient centrifugation. 
Culture 
CD4-8" cells were cultured at 1 x 106 cells/ml in the presence of 
1 x 106 cells/ml of an irradiated (6750 rads) allogeneic B lymphoblastoid 
line in 1.5 ml in 24 well tissue culture plates (Costar). The culture was 
stimulated with rIL-2, lOOu/ml (Hoffman LaRoche), and 1% phytahem- 
magluttinen (PHA) (Gibco). The final medium for all cultures is Iscove's 
modified Dulbecco's medium (Gibco) supplemented with 5% fetal calf 
serum (Hyclone), 1% penicillin-streptomycin (Gibco), and 1% glutamine 
(Whittaker). On day 10, the bulk culture was 'minicloned' at 10 
cells/well in 96 well U-bottomed plates (Costar). These cultures were 
maintained with rIL-2, lOOu/ml, 2X/week, and 0.4 x 106 cells/ml of 
irradiated feeder cells, as described above, lX/week, and were grown in 




1 x 103 cells were incubated with the appropriate antibodies 
(anti-CD3 hybridoma supernatant 1:4, OKT11 1:500, OKT4A 1:250, OKT8 
1:500, and WT31 1:1000 final dilution) at 4°C for 30 minutes. The cells 
were then washed and incubated in the fluoroscein-conjugated goat 
anti-mouse immunoglobulin (G/M FITC) (Meloy Laboratory) 1:100 final 
dilution at 4°C for 45 minutes and washed. Fluorescence was analysed 
on a model 30-H cytofluorograph (Ortho instruments). The results 
represent analysis of 103 cells for each population as indicated. 
Cytotoxicity 
The target cells: K562, U937, Molt4, Frolich, and B-Lymphoblastoid 
lines were grown under culture conditions as described above. Autolo¬ 
gous and allogeneic resting E+ and E- lymphocytes were obtained using 
Ficoll-Hypaque density gradient centrifugation and overnight rosette with 
a 5% SRBC solution. E+s were separated from SRBC with Tris-buffered 
ammonium chloride. Cells were maintained in medium at 37°C in a 
humidified atmosphere with 5% CO2 for 48 hours. 0.5 x 106 cells of 
each target population were treated with 24uCi 31Cr-chromium sodium 
(specific activity 200-500 uCi/mg of Cr) (New England Nuclear), in¬ 
cubated for 1 hour at 37°C, washed and placed at 5000 cells/well in 96 
well U-bottomed plates(Costar). Controls were the target cells alone 
and target cells plus lOOul 10% Triton solution in a final volume of 
200ul. The effector cells were added at the indicated E:T ratios in a 
final volume of 200ul. Where indicated, the effector cells were in¬ 
cubated with an anti MHC Class I mAb, W6/3277, (anti HLA-A, B, C 
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monomorphic determinant) (1:400) or anti-CD2 (1:400) for 30 minutes at 
4°C (before being added to the targets). After 5 hours incubation at 
37°C in a humidified atmosphere containing 5% CO2, lOOul of spun 
supernatant was removed from each sample and the 31Cr content mea¬ 
sured. Specific cytotoxicity was calculated as follows: 
(Experimental 31Cr release - Spontaneous 51Cr release)/(Total 
31Cr release - Spontaneous 31Cr release) 
Total 31Cr release was assessed by Triton lysis of the 31Cr-labelled 
cells, spontaneous 31Cr release was assayed in target cells alone. 
Proliferation 
5 x 104 DN cells were added to 5 x 104 resting E+ or E~ cells, 
obtained from normal adult blood as described above and irradiated (2250 
rads) in a final volume of 200ul of medium in 96 well U-bottomed tissue 
culture plate (Costar). Assays were performed in triplicate. The plates 
were maintained at 37°C in a humidified atmosphere containing 5% CO2. 
After 0, 3, and 6 days of culture, cells were harvested in a Mash II 
apparatus and the amount of 3H-thymidine incorporated over a 16 hour 
period was measured as counts/minute in a liquid scintillation counter. 
Reverse Hemolytic Plaque Assay 
In order to isolate a B-cell population from resting E~lymphocytes, 
the cells were incubated at 4°C for 20 minutes in anti-CD3 hybridoma 
supernatant (1:20 final dilution), washed, agitatated in rabbit complement 
(1:10) at 37°C for 1 hour, and then allowed to adhere to a large petri 
dish (Nunc) at 37°C for 1 hour. 2.5 x 104 B-cells were added to each 
tube and autologous T-cell populations at 10%, 50% and 100% of the 
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B — cell number were added as indicated. Pokeweed mitogen (Gibco) was 
added at a final dilution of 1:200 to appropriate samples. The final 
volume was 1 ml for each tube. Cells were incubated in culture condi¬ 
tions previously described for 7 days. Plaque assays were performed by 
adding lOul each of 11% SRBC coupled to rabbit anti-human IgG, guinea 
pig complement (1:2), and rabbit anti human IgG (1:100) to 50 ul cell 
suspension and suffusing the mixture into a chamber formed of taped 
microscope slides. This was incubated at 37°C for 1-2 hours and the 
plaques were counted. Plaque forming capacity equals the number of 
plaques/106 B-cells. 
RESULTS 
Initial Study of Peripheral DN 
CD4_8" cells were isolated from normal human peripheral E+ cells 
using negative selection with OKT8 and OKT4 mAb. This population is 
approximately 1-3% of the total circulating T-cell population. These 
cells did not react with WT31, a framework mAb to the TCRocP hetero¬ 
dimer, but were shown to be CD3+ upon cytofluorographic analysis. 
Immunoprecipitation with mAb to CD3 or Ty antisera revealed a 75K 
peptide which under reducing conditions resolved into a heterodimer of 
40K and 36K. The Tip and Tia peptides were not co-precipitated from 
the cell surface. 
In order to discover whether cells which do not have the Tioc|3 TCR 
and do express Ty mRNA perform known T-cell functions, cytotoxicity 
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assays were performed. The peripheral DN ceils demonstrated potent 
cytolytic activity towards K562 at a 20:1 effector to target ratio. They 
were spontaneously cytotoxic to K562 (84%), U937, a monocyte, (72%), an 
allogeneic B cell line, DR8, (23%), and autologous E" cells which were 
incubated overnight with 10% PWM and 50% irradiated E\ (53%). 
(Figure 3) Examination of the phenotype during the same period showed 
that the cells continued to be CD3*4_8_WT31~. 
Phenotype of Clones from Peripheral Blood 
The isolation of a CD4_8“ population of T cells from normal human 
blood was repeated and again the initial phenotype depicted a CD3 + 4_8~ 
WT31 “CD 1 ~ population. The culture was started with 1% PHA and was 
maintained with 11-2 and feeder ceils as above. In order to avoid the 
possibility that a subpopulation of NK cells was functioning the cells 
were 'minicloned' at 10 cells/well and subsequently 19 cell lines were 
maintained separately. The initial phenotype of these cells showed that 
they were all WT31- and that all but #19 were CD3 + . Ail lines were 
CD2 + . Phenotypes repeatedly performed alongside functional experiments 
demonstrated that the populations tested maintained stable profiles of 
CD3 + 4~8~WT31_ and CD2+ with the exception of #19 which continued to 
be CD3". 
In the periphery there is a heterogeneous population of CD2 + 4~8~ 
cells which can be divided into those with and those without CD3. It is 
most interesting that those clones which react to anti-CD3 antibody 
appear to be without the Tiaj3 which was formerly thought to be ex- 
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pressed in conjunction with CD3 after differentiation into CD4+ and 
CD8+ populations. 
The miniclones were later found to express Ty molecules which were 
coimmunoprecipitated with CD3. The clones did not express immunopre- 
cipitable Tor or T0. (Personal communication from Dr. Ilan Bank) 
Cytotoxicity 
In previous studies, phenotypically 'immature' cells with cytotoxic 
capacity, were isolated from thymus30; blood of an immunodeficiency 
patient42, a leukemic patient43,and a fetus44,43. These cell lines were 
postulated to represent a stage in thymic differentiation. Recent studies 
have shown that phenotypically similar populations isolated from the 
periphery also have cytotoxic function and may well represent a mature 
Ty population-46,47 In our preliminary study, we confirmed that the DN 
T-cells from the periphery are non-MHC restricted cytotoxic lym¬ 
phocytes. In order to further characterize this effector function, we 
compared a series of clones of peripheral DN cells according to their 
cytotoxic function. 
Target Range 
Peripheral blood lymphocytes, with the DN phenotype, at an effector 
to target ratio of 20:1, are spontaneously cytotoxic to K562, a cell line 
derived from an erythromyeloid precursor and notable for the absence of 
class I and class II HLA molecules. Miniclones MC9, MC11, and MC12 
were tested repeatedly and they demonstrated a capacity to kill at 
between 5-34% never reaching the levels of MC19 which was consistently 
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cytotoxic to K562 in the 70-80% range. MC9 generally had low to 
negligible levels of cytotoxicity to K562. One miniclone, hereafter MC4, 
was not, in repeated trials, cytotoxic to K562. 
Molt4, an immortal T-cell line, was also subject to killing by all of 
the peripheral DN clones except MC4, which was ineffective in 2 out of 
3 assays. (Figure 3.1) Similar data was obtained for another T-cell 
tumor line, Frolich, where MC4 had 0% cytotoxicity and MC11 lysed 14% 
of the target cells (data not shown). 
These cell lines were also repeatedly tested for cytotoxicity on 
U937, a monocytic cell line notable for having many Fc receptors. All 
of the miniclones were cytotoxic to U937 with MC8 having the highest 
levels with 39% cytotoxicity and MC9 the lowest at 9%. 
Continued cytotoxicity target range assays at an effector to target 
ratio of 20:1 revealed that MC4 was the only line which consistently was 
cytotoxic to its feeder B-lymphoblastoid cell line, BA. (Figure 3.2) 
Further studies showed that MC4 killed four other EBV immortalised 
B-cell lines including one (data not shown) begun from the autologous 
donor. The other clones; 9,11,and 12 had little to no cytolytic activity 
on these same cell lines. (Figure 4). 
The MCs 4, 9, 11, and 12 were, in general, less cytotoxic to targets 
than MC19 which is CD3-. Where MCs 9, 11, and 12 lyse K562, Molt4, 
U937 and Frolich to varying degrees, MC4 is only effective on U937 and 
immortalised B-cell lines including autologous B-cells. The possibility 
that MC4 is specific for HLA Class II or an EBV determinant is less 
than likely because it is also cytotoxic to U937. The peripheral DN 
clones are heterogeneous in their specificity. MC4 has a distinctly 
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different cytotoxic specificity from the other miniclones while maintain¬ 
ing the same phenotype. 
Non-MHC Restricted Cytotoxicity 
The clones appear to be non-MHC restricted in that they have the 
capacity to lyse cells which do not have class I or class II antigens 
(K562). This may be a nonspecific toxicity which coexists with a capa¬ 
city for a specific response dependent upon MHC antigen recognition. 
In order to examine this we used autogeneic and allogeneic cell lines as 
targets. Miniclones 9,11, and 12 were not at all cytotoxic to allogeneic 
or autologous resting E+ or E~ cells which had been incubated for 48 
hours before the assay. MC4 was only tested on autologous E~ cells and 
the results were inconclusive due to poor uptake of chromium by the 
targets. 
In an attempt to elucidate any possible role of the class I antigen in 
the recognition of the target we tested the cytotoxicity of clone 4 and 
clone 11 on the feeder cell line, and on K562 respectively after incuba¬ 
tion of the target with W6/32, an anti-MHC class I mAb. The cytotoxi¬ 
city of MC4 was greatly enhanced which was probably due to ADCC and 
should be repeated with blocking of Fc receptors. The cytotoxicity of 
MC11 was unchanged by the addition of W632 to the target. This would 
have to be repeated over a dose response curve to show that this was 




In further pursuit of the question of MHC restriction, we asked 
whether the DN miniclones would proliferate in response to autologous 
irradiated E-s? In repeated experiments, though E+ controls proliferated 
well in response to allogeneic E~s and slightly to autologous E~s on days 
3 and 6, none of the miniclones did so in response to either auto or 
allogeneic E-s. 
Helper Function 
We also wanted to know if these CD4~ cells could perform helper 
function and if so would there be any heterogeneity amongst the clones 
as seen in the cytotoxicity assays? MCs 4, 9, 11, and 12 were incubated 
with autologous resting B cells (isolated using anti CD3 and adherence) 
at ratios of 1:10, 1:2 and 1:1 of T-cell to B cell, with and without PWM, 
and assayed for plaque forming capacity on day seven. Without PWM 
there was no evidence of experimental inducer function. It is clear from 
the replicated results that in the presence of PWM both clone 9 and 11 
are able to function as helper cells and that clones 4 and 12 do not. 
(Figure 5) It is possible that clone 4 suppressed the B-cell activity. 
In the presence of MC4 there were fewer plaques formed than in the 
control which had no E+ lymphocytes. We have seen (Figure 4) that 
MC4 is cytotoxic to ail the B-cell lines which it has encountered. The 
question of this clone's cytotoxicity to PWM stimulated B-cells needs to 
be further tested. It will also be important to further delineate the 
limits of the helper capacity demonstrated by MCs 9 and 11. Once again 
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these phenotypically similar clones demonstrate a marked heterogeneity 
of effector capacity. Cells which do not express CD4, and are also 
capable of cytotoxicity, can function as inducers of B-cell response. 
DISCUSSION 
We have selected a CD4~8~ population from normal peripheral 
blood and observed along with Borst and Brenner that these clones are 
spontaneously cytotoxic to a broad range of non MHC restricted targets. 
The fact that the clones examined in this study have different 
target specificities, i.e. MC4 kills B cell lines and MCs 9,11, and 12 are 
cytotoxic to T cell tumor lines, supports the idea that this cytotoxicity 
is receptor mediated. The heterogeneous target specificity of cells 
which express the Ty but not the Tia|3 receptor, is an indication that 
the receptor is capable of antigen specificity. Further investigation of 
the function of the Ty receptor will be aided by the use of a mAb to 
the Ty receptor itself. 
One observation that arises is that simply by our selection technique 
we are isolating from the periphery a subset of, and therefore must 
include, NK cells in our experimental population. In fact, MC19, which 
is CD3- and is cytotoxic at very low doses to 'classic' NK targets, is 
probably an example of what Lanier would term an NK cell.78 The 
similarities of the DN clones to NK cells include: non MHC restricted 
cytotoxicity, the ability to perform ADCC, and the lack of need for sen¬ 
sitization to the target of cytotoxicity. Though our data as to the 
effect of CD3 on the function of the Ty receptor is inconclusive, Borst, 
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Brenner and Moingeon interpreted their data to show that CD3 is func¬ 
tioning on cells with the Ty receptor. The presence of a CD3 molecule 
associated with a receptor serves to distinquish this population from 
other cells with NK function. The prediliction of one of these cell lines 
for B-cell lines also serves to distinquish cells of this phenotype from 
other cells with 'NK like' function. This particular specificity would be 
very rare for a CD3~ cell line. Another point of difference between Ty 
expressing cells and NK cells is that there is a population of T cells 
found in the thymus which is not the case for those of NK lineage.79 
Our data reconfirm that this population is cytotoxic to a broad 
range of cells and does not discriminate between self and nonself. MC4 
kills its own activated B-cell line but not autologous E- lymphocytes. 
Reinhertz aptly questions the non-MHC restricted quality of DN cyto¬ 
toxicity.73 The broad range of targets killed by these clones may be an 
in vitro phenomenon quite apart from an MHC restricted specificity as 
yet unmeasured. Our finding that some of the clones (MCs 11 and 9) 
function as helper cells in an autologous system highlights the fact that 
further study of MHC recognition by these cells is necessary. 
In considering the purpose of this new receptor one must return to 
the question of lineage. Do different populations of cells with func¬ 
tioning Ty receptors represent stages in the development of the Ty 
receptor or is the Ty , as Raulet et al. assert, itself necessary for the 
functional maturation of the Tia3 receptor? Borst and Brenner postualte 
that the Ty genetic rearrangement takes place in the thymus and that 
the Tv expressing cells which are isolated from the periphery are mature 
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examples of this receptor. In other words Ty expressing cells are a 
separate fully differentiated subset of T-cells. 
Evidence that the Ty and the Tia3 are separate branches of cell 
lines with a common precursor, perhaps entirely different lineages, or 
even coexpressed would not preclude the Ty expressing cells from having 
a role such as that proposed in the thymic education of the preponder¬ 
ant T-cell receptor. The observation that Ty mRNA production is in¬ 
creased during fetal life when MHC restriction is thought to be deter¬ 
mined makes it a tempting participant in the selection of self recogniz¬ 
ing clones. Pernis speculates that dual recognition is accomplished by a 
'one and a half receptor' model composed of a complex of a(3CD33 
where Tiocg recognizes antigen and 3y recognizes self MHC encoded 
molecules.10 
It is also entirely possible, as suggested by Reinhertz and Nakanishi, 
that the Ty receptor is simply an evolutionary footnote, with a distinc¬ 
tion from the TiafJ similar to that between the K and A light chains.80 
Perhaps the increased level of Ty mRNA during fetal life is simply 
ontogeny recapitulating phylogeny. Discovering the genetic lineage and 
expression of the T-cell receptor(s) in humans is important in giving us 
clues to the role, if there is one, for Ty in T-cell development. We 
have demonstrated that some Ty expressing cells have helper and cyto¬ 
toxic function, and that the cytotoxicity itself varies in range from 
clone to clone indicating that the receptor is capable of some degree of 
antigen specificity. 
In summary, a receptor which is detected genetically in an early 
stage of T-cell development is found on T-cells from healthy adult 
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human peripheral blood. The Ty molecule is expressed in the context of 
CD3 but without the Tia(3 TCR. Neither does it appear with CD4 or 
CD8, the markers of helper and suppressor T-cells. It is possible that Ty 
expressing cells represent a distinct cell line with intermediate function¬ 
al and antigen recognition capacity relative to the Tia|3 TCR. The 





Model of TCR/CD3 Complex* 
The TCR heterodimer of a (48-54 K) disulfide bonded to 
3 (40-44K) is in a complex with the CD3 molecule composed of y 
(25 K), £ (20 K), and 5 (20 K). The functional connection bet¬ 
ween the TCR and CD3 may be mediated by a structural link 
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Initial DN Cytotoxicity 
Target Cells 
CD3f4'8"WT31~ T-cells maintained in culture are cytotoxic to K562, 
U937, an allogeneic B-cell line (DR8allo), and autologous E~ cells at a 
20:1 effector to target ratio. Data represent the mean percent specific 
31Cr released ± sem of triplicate assays. 
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CD4-8- Clone Numbers 
CD4-8~ clones demonstrate heterogeneous cytotoxicity to K562 (top) 
and U937 (bottom) at a 20:1 effector to target ratio. A five hour 51Cr 






































Ail MCs are cytotoxic to U937, and only MC4 is cytotoxic to BA, a 
B-cell line. CD 4'8" clones were incubated with 31Cr labelled U937 (bot¬ 
tom) or BA (top) at a 20:1 e:t ratio. Data represent the mean of tripli¬ 
cate assays ± sem. 

Figure 4. 































M04 alone, is cytotoxic to S-cells. CD4-8- T-ceils were tested for 
cytotoxicity to a) K'562, a standard \"K target, b) U937, a monocyte, c) 
BA, a^B-cell line, and B-cell lines of different DR specificities d) 3161, 
e)682/, and f)682L Targets were labelled with 3LCr and incubated at a 
-0.1 e.t ratio for 5 hours. Percent specific cytotoxicity is the mean ± 



















Figure 5 Inducer Function 
MC 4 o 
MC 9 ° 
MC 11 A 
MC 12 • 
Ratio of CD4“8_ cells: B-cells 
MC cells exhibit heterogeneous helper function. CD4*8_ T-cells 
were added in ratios of 1:10, 1:2, and 1:1 to 0.25 x 106 autologous 
B-cells with PWM at 1:200 and plaque forming capacity (PFC) was as¬ 
sayed 7 days later. (See reverse hemolytic plaque assay in Materials and 
Methods). Controls were the B-cells with PWM 1:200 in medium (*) and 
in the presence of 100% that number of autologous E+ cells (*). Assays 
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